Glutamate-dopamine interactions mediate the effects of psychostimulant drugs

Addiction Biology

Volumn 4, Issue 2, 1999, Pages 141-150

  Wang, John Q ^a   McGinty, Jacqueline F ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; GLUTAMIC ACID;

CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; DRUG ACTIVITY; DRUG MECHANISM; GENE EXPRESSION; NERVE CELL; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0032904108     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556219971641     Document Type: Review

References (80)

1. Smith Y, Bennett BD, Bolam JP, Parent A, Sadikot AF. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J Comp Neurol 1994;344:1-19.
2. Lapper SR, Bolam JP. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuron-science 1992;51:533-45.
3. Pickel VM, Chan J, Sesack SR. Cellular basis for interactions between catecholaminergic afferents and neurons containing Leu-enkephalin-like immunoreactivity in rat caudateputamcn nuclei. J Neurosci Res 1992;31:212-30.
4. Bouyer JJ, Park DH, JohTH, Pickel VM. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res 1984;302: 267-76.
5. Albin RL, Makowiec RL, Hollingsworth ZR, Dure IVLS) Penney JB, Young AB. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 1992;46:35-48.
6. Greenamyre JT, Young AB. Synaptic localization of striatal NMDA, quisqualate and kainate receptors. Neurosci Lett 1989;101:133-7.
7. Wullner U, Testa CM, Catania MV, Young AB, Penney JB Jr. Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res 1994;645:98-102.
8. Tallaksen-Greene SJ, Wiley RG, Albin RL. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neuron. Brain Res 1992;594:165-70.
9. Sato K, Kiyama H, Tohyama M. The differential expression patterns of messeger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 1993;52:515-39.
10. Standaert DG,Testa CM, Young AB, Penney JB Jr. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 1994;343:1-16.
11. Tallaksen-Greene SJ, Albin RL. Localization of AMPA-selective excitatory amino acid receptor subunits in identified population of striatal neurons. Neuroscience 1994;61:509-19.
12. Norman AB, Ford LM Kolmonpunporn M, Sanberg PR. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum. Euro J Pharmacol 1990;176:363-6.
13. Martin LJ, Blackstone CD, Huganir RL, Price DL. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron 1992;9:259-70.
14. Testa CM, Standaert DG, Young AB, Penney JB Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 1994; 14:3005-18.
15. Karler R, Calder LD, Chaudhry IA, Turkanis SA. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 1989;45: 599-606.
16. Ohmori T, Abekawa A, Muraki A, Koyama T. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamin Pharmacol Biochem Behav 1994;48:587-91.
17. Stewart J, Druhan JP. The development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the noncompetitive NMDA receptor antagonist, MK-801. Psychopharmacology 1993;110: 125-32.
18. Wolf ME, Jeziorski M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 1993; 613:291-4.
19. Karler R, Calder LD, Turkanis SA. DNQX blockade of amphetamine behavioral sensitization. Brain Res 1991;552:295-300.
20. Karler R, Calder LD, Bedingfield JB. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology 1994; 115: 305-10.
21. Bristow LJ, Thorn L, Tricklebank MD, Hutson PH. Competitive NMDA receptor antagonists attenuate the behavioral and neurochemical effects of amphetamine in mice. Euro J Pharmacol 1994; 264:353-9.
22. Witkin JM. Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci 1993;53:405-10.
23. Karler R, Calder LD, Thai L, Bedingfield JB. The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine. Brain Res 1995;671:100-4.
24. Kelley AE, Throne LC. NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res Bull 1992;29: 247-54.
25. Pulvirenti L, Swerdlow NR, Koob GF. Micro-injection of glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Ncurosci Lett 1989; 103:213-18.
26. Willins DL, Wallace LJ, Miller DD, Uretsky NJ. α-Amino-3-hydroxy-5-methylisoxazole-4-propio-nate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs. J Pharmacol Exp Ther 1992;260:1145-51.
27. Arnt J. Hyperactivity following injection of a glutamate agonist and 6, 7-ADTN into rat nucleus accumbens and its inhibition by THIP. Life Sci 1981;28:1597-603.
28. Hooks MS, Kalivas PW. Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. J Pharmacol Exp Ther 1994;269:976-88.
29. Thanos PK, Jhamandas K, Beninger RJ. N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptamoic acid and cis-flupenthixol. Brain Res 1992;589: 55-61.
30. Nestler EJ. Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 1997;7: 713-19.
31. Johnson M, Bush LG, Gibb JW, Hanson GR. Blockade of the 3, 4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A system. Eur J Pharmacol 1991;193: 367-70.
32. Johnson M, Bush LG, Gibb JW, Hanson GR. Role of N-methyl-D-aspartate (NMDA) receptors in the response of extrapyramidal neurotension and dynorphin A system to cocaine and GBR12909. Biochem Pharmacol 1991;41:649-52.
33. Singh NA, Midgley LP, Bush LG, Gibb JW, Hanson GR. N-Methyl-D-aspartate receptors mediate dopamine-induccd changes in extrapyramidal and limbic dynorphin systems. Brain Res 1991;555:233-8.
34. Dragunow M, Logan B, Laverty R. 3,4-methylene-dioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK-801. Eur J Pharmacol 1991;206:255-8.
35. Snyder-Keller, AM. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp Neurol 1991;113:155-65.
36. Torres G, Rivers C. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res Bull 1993;30: 173-6.
37. Ohno M, Yoshida H, Watanabe S. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization. Brain Res 1994;665:135-40.
38. Wang JQ, McGinty, JF. Alterations in striatal zif/ 268, preprodynorphin and prcproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res 1995;673: 262-74.
39. Wang JQ, Smith AJW, McGinty JF. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin mRNA expression in rat forebrain. Neuroscience 1995;68:83-95.
40. Wang JQ, Daunais JB, McGinty, JF. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 1994; 18: 343-53.
41. Wang JQ, Daunais JB, McGinty, JF. Role of kainate/AMPA receptors in induction of striatal zif/ 268 and preprodynorphin mRNA by a single injection of amphetamine. Mol Brain Res 1994;27: 118-26.
42. Wang JQ, McGinty JF. Acute methamphetamine-induced zif/268, preprodynorphin and preproenkephalin mRNA expression in rat striatum depends upon activation of NMDA and kainate/AMPA receptors. Brain Res Bull 1996;39:349-57.
43. 1 dopamine receptor-mediated induction of zif/268 and c-fos in the dopamine-depletcd striatum: differential regulation and independence from NMDA receptors. J Comp Neurol 1996;367:165-76.
44. Berretta S, Robertson HA, Graybiel AM. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J Neurophysiol 1992;68:767-77.
45. Page KJ; Everitt BJ. Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neuron following AMPA-induced activation of the dorsal and ventral striatum. Exp Brain Res 1993; 93:399-411.
46. Vaccarino FM, Hayward MD, Nestler EJ, Duman RS, Tallman JF. Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons. Mol Brain Res 1992; 12:233-41.
47. Garcia-Munoz M, Young SJ, Groves PM. Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation. Brain Res 1991;551:207-15.
48. Worley PF, Christy BA, Nakabeppu Y, Bhat RV, Cole AJ, Baraban JM. Constitutive expression of zif/268 in neocortex is regulated by synaptic activity. Proc Natl Acad Sci USA 1991;88:5106-10.
49. 5-enkephalin biosynthesis in neurons of the rat striatum. J Pharmacol ExpTher 1992;262:823-33.
50. Wang JQ, McGinty JF. Glutamatergic and cholinergic regulation of immediate early gene and neuropeptide gene expression in the striatum. In: Merchant K, editor. Pharmacological regulation of gene expression in the CNS. Boca Raton: CRC Press Inc., 1996;81-113.
51. Yamamoto BK, Davy S. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J Neurochem 1992;58:1736-42.
52. Reid MS, Hsu K Jr, Berger SP. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: Studies on the involvement of dopamine. Synapse 1997;27: 95-105.
53. Smith JA, Mo Q, Guo H, Kunko PM, Robinson SE. Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain Res 1995;683:264 9.
54. Dalla A, Uretsky NJ, Wallace LJ. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellualr glutamate and on locomotor activity. Brain Res 1998;788:111-17.
55. Gray AM, Rawls M, McGinty JF. The kappa opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and dialysate levels of dopamine and glutamate in the nucleus accumbens of awake rats (submitted).
56. McGinty, JF, Rawls SM, Gray AM. Amphetamine-induced striatal dopamine and glutamate levels are partially calcium-dependent. Abs Soc Neurosci 1998;24:1993.
57. Pierce RC, Bell K, Duffy P, Kalivas PW. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 1996;16:1550-6.
58. Reid MS, Berger SP. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. NeuroReport 1996;7:1325-9.
59. Fisher JF, Cho AK. Chemical release of dopamine from striatal homogcnates: evidence of an exchange diffusion model. J Pharmacol Exp Ther 1979;208: 203-9.
60. 1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. J Neurosci 1997; 17: 8498-505.
61. 1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 1995;15:5379-88.
62. Cole RL, Konradi C, Douglass J, Hyman SE. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 1995; 14: 813-23.
63. Konradi C, Cole RL, Green D, et al. Analysis of the proenkephalin second messenger-induciblc enhancer in rat striatal cultures. J Neurochem 1995;65: 1007-15.
64. Greenberg ME, Thompson MA, Sheng M. Calcium regulation of immediate early gene transcription. J Physiol 1992;86:99-108.
65. 2+/calmodulin- as well as cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1991;88:5061-5.
66. 2+ - and stimulus duration-dependent switch for hippocampal gene expression. Cell 1996;87:1203-14.
67. Ginty DD. Calcium regulation of gene expression; isn't that spatial? Neuron 1997;18:183-186.
68. Ginty DD, Bading H, Greenberg ME. Transsynaptic regulation of gene expression. Curr Opin Neurobiol 1992;2:312-16.
69. 1 dopamine receptors through a cAMP-dependent mechanism. Nature 1990;348: 239-42.
70. 2+ channels due to phosphorylation by cAMP-dependent protein kinase. Nature 1993;364:240-3.
71. Chetkovich DM, Sweatt JD. NMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. J Neurochem 1993;61: 1933-42.
72. Aszodi A, Muller U, Friedrich P, Spatz HC. Signal convergence on protein kinase A as a molecular model of learning. Proc Natl Acad Sci USA 1991; 88:5832-6.
73. 2+ influx requires cAMP-dependent protein kinase in PC12 cells. J Biol Chem 1991;266: 17454-8.
74. Konradi C, Leveque JC, Hyman SE. Amphetamine and doparnine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurose 1996;16:4231-9.
75. Sacaan AI, Monn JA, Schoepp DD. Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat. J Pharmacol Exp Ther 1991; 259: 1366-70.
76. Wang JQ. Regulation of immediate early gene c-fos and zif/268 mRNA expression in rat striatum by metabotropic glutamate receptor. Mol Brain Res 1998;57:46-53.
77. Wang JQ, McGinty JF. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Mol Brain Res 1998;54: 262-9.
78. Verma A, Moghaddam B. Regulation of striatal dopamine release by metabotropic glutamate receptors. Synapse 1998;28:220-6.
79. Wang JQ, McGinty JF. Intrastriatal injection of the metabotropic glutamate receptor antagonist MCPG attenuates acute amphetamine-stimulated neuropeptide mRNA expression in rat striatum. Neurosci Lett 1996;218:13-16.
80. Wang JQ, Mao L. Sustained behavioral stimulation following selective activation of group I metabotropic glutamate receptors in the rat striatum. J Pharmacol Exp Ther (submitted).